Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes

International Journal of Cardiology

Volumn 150, Issue 3, 2011, Pages 325-331

  Biondi Zoccai, Giuseppe ^a   Lotrionte, Marzia ^b   Agostoni, Pierfrancesco ^c   Abbate, Antonio ^d   Romagnoli, Enrico ^e   Sangiorgi, Giuseppe ^f   Angiolillo, Dominick J ^g   Valgimigli, Marco ^h   Testa, Luca ⁱ   Gaita, Fiorenzo ^a   Sheiban, Imad ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

^h UNIVERSITY OF FERRARA   (Italy)

ⁱ S Ambrogio Clinical Institute   (Italy)

Author keywords

Acute coronary syndrome; Meta analysis; Prasugrel; Ticagrelor

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PRASUGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MALE; META ANALYSIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE;

ACUTE CORONARY SYNDROME; ADENOSINE; HUMANS; PIPERAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIOPHENES; TREATMENT OUTCOME;

EID: 79960555699     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.035     Document Type: Article

References (25)

1. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
2. L. Testa, G.B. Zoccai, and I. Porto Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 vs. aspirin plus clopidogrel after acute coronary syndromes Am J Cardiol 99 2007 1637 1642 (Pubitemid 46874317)
3. M. Lotrionte, D. Castagno, and P. Agostoni Long-term effect of chronic oral anticoagulation: focus on coronary artery disease Future Cardiol 5 2009 259 271
4. M. Lotrionte, G.G. Biondi-Zoccai, and P. Agostoni Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention Am J Cardiol 100 2007 1199 1206
5. S.D. Wiviott, E. Braunwald, and C.H. McCabe TRITON-TIMI 38 Investigators. Prasugrel vs. clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
6. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor vs. clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
7. H.C. Bucher, G.H. Guyatt, L.E. Griffith, and S.D. Walter The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 1997 683 691 (Pubitemid 27341818)
8. F. Song, D.G. Altman, A.M. Glenny, and J.J. Deeks Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analysis BMJ 326 2003 472
9. G.G. Biondi-Zoccai, P. Agostoni, and A. Abbate Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials Int J Cardiol 100 2005 119 123 (Pubitemid 40487945)
10. G.G. Biondi-Zoccai, M. Lotrionte, and A. Abbate Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- vs. paclitaxel-eluting stents across 5854 patients Int J Cardiol 114 2007 104 105 (Pubitemid 44802889)
11. G.G. Biondi-Zoccai, P. Agostoni, A. Abbate, L. Testa, and F. Burzotta A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials Int J Epidemiol 34 2005 224 225 (Pubitemid 40347400)
12. C.P. Cannon, S. Husted, and R.A. Harrington Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial J Am Coll Cardiol 50 2007 1844 1851 (Pubitemid 350007959)
13. S.D. Wiviott, E.M. Antman, and K.J. Winters Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial Circulation 111 2005 3366 3373 (Pubitemid 40931949)
14. S.D. Wiviott, D. Trenk, and A.L. Frelinger Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial Circulation 116 2007 2923 2932 (Pubitemid 350291199)
15. R.A. Harrington, G.W. Stone, and S. McNulty Platelet inhibition with cangrelor in patients undergoing PCI N Engl J Med 361 2009 2318 2329
16. J.S. Berger, M.T. Roe, and C.M. Gibson Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial Am Heart J 158 2009 998 1004 e1
17. S. Eshaghian, P.K. Shah, and S. Kaul Advances in antiplatelet treatment for acute coronary syndromes Heart 96 2010 656 661
18. L. Testa, R. Bhindi, W.J. Van Gaal, R.A. Latini, S. Pizzocri, and S. Lanotte What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel QJM 103 2010 367 377
19. T. Chechi, S. Vecchio, and G. Vittori ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients J Am Coll Cardiol 51 2008 2396 2402 (Pubitemid 351833104)
20. G.G. Biondi-Zoccai, M. Lotrionte, and C. Moretti A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease Am Heart J 155 2008 274 283
21. G.G. Biondi-Zoccai, P. Agostoni, and G.M. Sangiorgi Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study Int J Cardiol 108 2006 406 407 (Pubitemid 43339814)
22. G.G. Biondi-Zoccai, A. Abbate, and P. Agostoni Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression Am Heart J 149 2005 504 511 (Pubitemid 40590040)
23. P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable cornonary disease: The ONSET/OFFSET Study Circulation 120 2009 2577 2585
24. F. Song, I. Harvey, and R. Lilford Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions J Clin Epidemiol 61 2008 455 463 (Pubitemid 351446184)
25. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150